These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12644343)

  • 1. Oral anticoagulants in patients with coronary artery disease.
    Anand SS; Yusuf S
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):62S-69S. PubMed ID: 12644343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
    Anand SS; Yusuf S
    JAMA; 1999 Dec; 282(21):2058-67. PubMed ID: 10591389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial.
    van Es RF; Jonker JJ; Verheugt FW; Deckers JW; Grobbee DE;
    Lancet; 2002 Jul; 360(9327):109-13. PubMed ID: 12126819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes associated with combined antiplatelet and anticoagulant therapy.
    Johnson SG; Rogers K; Delate T; Witt DM
    Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001342. PubMed ID: 16855967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy.
    Ornato JP
    Health News; 2002 Nov; 8(11):3. PubMed ID: 12523247
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
    Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
    Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
    Redman AR; Allen LC
    Curr Atheroscler Rep; 2002 Jul; 4(4):319-25. PubMed ID: 12052284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin, aspirin, or both after myocardial infarction.
    Hurlen M; Abdelnoor M; Smith P; Erikssen J; Arnesen H
    N Engl J Med; 2002 Sep; 347(13):969-74. PubMed ID: 12324552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.
    Andreotti F; Testa L; Biondi-Zoccai GG; Crea F
    Eur Heart J; 2006 Mar; 27(5):519-26. PubMed ID: 16143706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
    Kopin D; Jones WS; Sherwood MW; Wojdyla DM; Wallentin L; Lewis BS; Verheugt FWA; Vinereanu D; Bahit MC; Halvorsen S; Huber K; Parkhomenko A; Granger CB; Lopes RD; Alexander JH
    Am Heart J; 2018 Mar; 197():133-141. PubMed ID: 29447773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.